by L Straub 2024 Cited by 32took antipsychotic drugs Women taking any antipsychotic medication during pregnancy aripiprazole during the second half of pregnancy
antipsychotic drugs. Clinical manifestations of NMS are hyperpyrexia pregnancy outcomes in women exposed to atypical antipsychotics, including
Antipsychotic drug use in pregnant women appears to pose minimal risk, new study suggests Study suggests antipsychotic drugs during pregnancy
Pregnancy: Non-Teratogenic Effects – Neonates exposed to antipsychotic drugs during the third trimester of pregnancy are at risk for
by Ó Hálfdánarson 2024 Cited by 25ADHD, but not between treatment with antipsychotics during pregnancy and ADHD in children. Antipsychotic drugs in pregnancy: a review of their maternal
antipsychotic drugs. Clinical manifestations of NMS are hyperpyrexia pregnancy outcomes in women exposed to atypical antipsychotics, including
Comments: -A pregnancy exposure registry is available. -Neonates exposed to antipsychotic drugs during the third trimester of pregnancy are at
antipsychotic drugs are at an pregnancy outcomes in women exposed to atypical antipsychotics, including UZEDY, during pregnancy.
Pregnancy: Neonates exposed to antipsychotic drugs, including aripiprazole, during the third trimester of pregnancy are at risk for extrapyramidal and/or
Comments